Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.15 USD | -0.94% | -2.17% | +55.94% |
10/05 | Leerink Partners Starts Aquestive Therapeutics With Outperform Rating, $8 Price Target | MT |
08/05 | Transcript : Aquestive Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.94% | 287M | |
+37.74% | 723B | |
+34.45% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+17.00% | 244B | |
+10.04% | 208B | |
-4.13% | 205B | |
+7.43% | 166B |
- Stock Market
- Equities
- AQST Stock
- News Aquestive Therapeutics, Inc.
- Transcript : Aquestive Therapeutics, Inc., Q2 2022 Earnings Call, Aug 03, 2022